Michaelj Pishvaian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesSalt lake cityFrance generalMichaelj pishvaianShaun bagaiGustave roussyFrontpagestocks corporateadsShripal gandhiMichel ducreuxResearch supports renovorx lead oncology productRenovorx incImugene ltdMiami cancer instituteUniversity of paris sudData monitoring committeeGastrointestinal tract cancer group

Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)

Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalMichaelj pishvaianFrontpagestocks corporateadsShripal gandhiMichel ducreuxGustave roussyRenovorx incSaclay universityEuropean organisation for researchClinical trials in partnershipImugene ltdGastrointestinal tract cancer groupCompany scientific advisory boardMiami cancer instituteSchool of medicine

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights

RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJack perkinsMichaelj pishvaianShripal gandhiShaun bagaiVascular instituteCompany nasdaqMiami cancer instituteExchange commissionImugene ltdNasdaq stock marketSchool of medicineStrategic communicationsData monitoring committeeRenovorx incSecurities exchange

RenovoRx, Inc Stock Surges After Reporting Positive Data From Its Phase III TIGeR-PaC Trial ($RNXT)

RenovoRx, Inc. shares surged by 37% on massive volume after the company provided a positive update from its TIGeR-PaC trial. While profit-taking took the momentum from the rally, RNXT shares are.

Columbia universityNew yorkUnited statesShaun bagaiMichaelj pishvaianMichael thomasTiger pac data monitoring committeeUt southwestern medical centerStm llcRenovorx incWorld congress on gastrointestinal cancerPresbyterian hospital irving medical centerShore thing mediaUniversity of texas ut southwestern medical centerGastrointestinal cancerHopkins medicine

Intra-arterial gemcitabine extends PFS in locally advanced pancreatic cancer

Intra-arterial gemcitabine extends PFS in locally advanced pancreatic cancer
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Michaelj pishvaianMindy valcarcelBymatthew shinkleWorld congress on gastrointestinal cancerGastrointestinal cancer